In Astellas Pharma Inc. v. Sandoz Inc., the US Court of Appeals for the Federal Circuit vacated a sua sponte district court ruling that found Astellas’s asserted patent ineligible under Title 35 ...
“Even if this Court were inclined to do so, neither party has been able to point to any authority, and the Court is unable to find any sua sponte, which allows it to run a sentence concurrent ...
“The extent of [Lee’s] work on this matter is limited to his notice of appearance and so-called sua sponte withdrawal order.” And, the report noted, the client didn’t know Lee had withdraw ...